PortfoliosLab logo

AN2 Therapeutics Inc (ANTX)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in AN2 Therapeutics Inc in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,747 for a total return of roughly -42.53%. All prices are adjusted for splits and dividends.

ANTX (AN2 Therapeutics Inc)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ANTX

AN2 Therapeutics Inc


AN2 Therapeutics Inc had a return of -7.14% year-to-date (YTD) and -42.53% in the last 12 months.

1 month-35.87%-5.31%
6 months4.12%0.39%
1 year-42.53%-13.79%
5 years (annualized)N/AN/A
10 years (annualized)N/AN/A

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The chart below displays rolling 12-month Sharpe Ratio.

Chart placeholderNot enough data

Dividend History

AN2 Therapeutics Inc doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ANTX (AN2 Therapeutics Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the AN2 Therapeutics Inc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AN2 Therapeutics Inc is 64.38%, recorded on Mar 16, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-64.38%Aug 16, 2022147Mar 16, 2023
-59.56%May 9, 202258Aug 1, 20229Aug 12, 202267
-13.49%Apr 5, 20225Apr 11, 202212Apr 28, 202217
-2.6%Mar 28, 20223Mar 30, 20222Apr 1, 20225
-1.82%Apr 29, 20221Apr 29, 20221May 2, 20222
-1.31%May 3, 20221May 3, 20221May 4, 20222

Volatility Chart

Current AN2 Therapeutics Inc volatility is 76.61%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ANTX (AN2 Therapeutics Inc)
Benchmark (^GSPC)